Under construction – not a live service
Sign in
Taking people in FranceNo phase

Rheopheresis added to standard care for calciphylaxis in hemodialysis patients

Tests rheopheresis, a blood-filtering procedure, in adults on dialysis with calciphylaxis.

Plain-language title generated from the registry record
Registry title: Rheopheresis as Adjuvant Treatment of Calciphylaxis

Key facts

Where
Angers, Arras, Auxerre, Besançon, Béthune, Boulogne-sur-Mer, Bourdeaux, Brest, Caen, Grenoble, Laval, Le Mans, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Niort, Reims, Toulouse, Valenciennes, Vandœuvre-lès-Nancy, Vannes, and Vichy, FranceSee the 29 sites

Where in France

  • CHU d AngersAngers, FranceNot yet recruiting
  • CHU d'ArrasArras, FranceTaking people
  • CHU d'AuxerreAuxerre, FranceNot yet recruiting
  • CHU de Besancon - Hopital Jean MinjozBesançon, FranceTaking people
  • CH de BéthuneBéthune, FranceTaking people
  • CH de Boulogne-sur-MerBoulogne-sur-Mer, FranceTaking people
  • CHU de BordeauxBourdeaux, FranceNot yet recruiting
  • CHRU de BrestBrest, FranceNot yet recruiting
  • CHU de CAENCaen, FranceNot yet recruiting
  • Hôpital Nord Michallon, CHU de GrenobleGrenoble, FranceTaking people
  • Centre ECHO LavalLaval, FranceTaking people
  • Centre ECHO Le MansLe Mans, FranceTaking people
  • Hop Claude Huriez Chu LilleLille, FranceTaking people
  • Hôpital Privé La LouviereLille, FranceTaking people
  • CHR de LimogesLimoges, FranceTaking people
  • Hopital Lyon SudLyon, FranceNot yet recruiting
  • Hôpital Saint Joseph Saint LucLyon, FranceNot yet recruiting
  • Hôpital de la Conception, AP-HMMarseille, FranceTaking people
  • Institut Phocéen de Néphrologie - Clinique BouchardMarseille, FranceNot yet recruiting
  • CHU de MontpellierMontpellier, FranceTaking people
  • CHU de NantesNantes, FranceTaking people
  • CH de NiortNiort, FranceNot yet recruiting
  • CHU de ReimsReims, FranceTaking people
  • CHU de ToulouseToulouse, FranceTaking people
  • Clinique Saint ExupéryToulouse, FranceNot yet recruiting
  • CH de ValenciennesValenciennes, FranceTaking people
  • Chru de Nancy-BraboisVandœuvre-lès-Nancy, FranceNot yet recruiting
  • Centre Hospitalier Bretagne AtlantiqueVannes, FranceNot yet recruiting
  • CH de VichyVichy, FranceNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Lille
Trial code
NCT04654000
Record updated
12 February 2026
Original description
The investigators propose to set up a prospective randomized controlled trial to control the security and assess the efficacy of adjuvant treatment by rheopheresis in necrotizing-ulcered calciphylaxis in the hemodialysis population.Read full original descriptionShow less

Efficacy of Rheopheresis as Adjuvant Treatment of Calciphylaxis in Hemodialysis Patients : a Prospective Randomized Controled Single-blind Trial

The investigators propose to set up a prospective randomized controlled trial to control the security and assess the efficacy of adjuvant treatment by rheopheresis in necrotizing-ulcered calciphylaxis in the hemodialysis population.

Inclusion: Calciphylaxis with at least one ulcerated or necrotizing lesion; End stage renal disease requiring hemodialysis; Weight superior to 30kg; Subject affiliated to or beneficiary of a social security system; Subject having signed written informed consent; A patient with progressing calciphylaxis to ulcerate or necrosis despite conventional treatment may also be included.

Exclusion: Uncontrolled infection (persistence of fever despite appropriate antibiotic therapy); Severe cognitive or psychiatric disorders, patients unable to give an informed consent or unwilling to participate in the study; Albumin allergy; KARNOFSKY Performance Status Scale inferior to 30%; Life expectancy (independently of calciphylaxis) estimated < 6 months according to a referring physician expert in hemodialysis; Common variable immunodeficiency; Contra-indication to stop anti-vitamin K treatment; Pregnancy or breastfeeding and all the other categories of people with special protection according to the French Code de la Santé Publique (CSP): patients under legal supervision, patients hospitalized without contentment, patients admitted in social or sanitary structures for care and not research, and patients in emergency situations.

ClinicalTrials.gov NCT04654000